← Leaderboards
Michael Richard Green
University Of Tx Md Anderson Can Ctr
$8,960,138
Attributed
$11,391,933
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,391,933 · 6
By mechanism
R01$10,226,025 · 4
P01$787,233 · 1
R21$378,675 · 1
Top collaborators
- Christopher Edward Mason4 shared
- Margarida Santos4 shared
- Paolo Strati1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Kapil N. Bhalla$16,921,043
- Srdan Verstovsek$1,168,238
- Margarida Santos$1,372,502
- Rugang Zhang$23,913,209
- Sattva S Neelapu$3,334,171
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaGenesB-Cell DevelopmentMutationLymphomagenesisB-LymphocytesComplexTumorCell LineStructure Of Germinal Center Of Lymph NodePhenotypePlayLymphomaGeneticPatient Derived Xenograft ModelMediatingMouse ModelCellsTranscription FactorB-Cell LymphomasEpigenetic ProcessMalignant NeoplasmsMutantNon-Hodgkin&Apos
Grant awards (26)
BAF complex deregulation in lymphoma$686,111
R01 · FY2025 · CA · contact PI
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$453,454
R01 · FY2025 · CA · contact PI
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$440,932
R01 · FY2025 · CA · contact PI
Project 4 Green-Davis$391,178
P01 · FY2025 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$329,703
R01 · FY2025 · CA · contact PI
BAF complex deregulation in lymphoma$651,802
R01 · FY2024 · CA · contact PI
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$430,783
R01 · FY2024 · CA
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$418,885
R01 · FY2024 · CA · contact PI
Project 4 Green-Davis$396,055
P01 · FY2024 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$348,019
R01 · FY2024 · CA · contact PI
BAF complex deregulation in lymphoma$672,389
R01 · FY2023 · CA · contact PI
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$444,385
R01 · FY2023 · CA
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$432,113
R01 · FY2023 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$359,009
R01 · FY2023 · CA · contact PI
BAF complex deregulation in lymphoma$701,610
R01 · FY2022 · CA · contact PI
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$444,382
R01 · FY2022 · CA
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$432,113
R01 · FY2022 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$381,836
R01 · FY2022 · CA · contact PI
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$453,454
R01 · FY2021 · CA
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$440,932
R01 · FY2021 · CA · contact PI
Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma$378,675
R21 · FY2021 · CA
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$340,445
R01 · FY2020 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$330,230
R01 · FY2019 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$340,445
R01 · FY2018 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$356,616
R01 · FY2017 · CA · contact PI
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$336,377
R01 · FY2016 · CA · contact PI